SEC Filing Summary: Prestige Brands Holdings, Inc. (8-K)
Business Context and Reporting Period
This Form 8-K was filed on May 1, 2014, reporting events occurring on April 30, 2014. The registrant, Prestige Brands Holdings, Inc., is a Delaware corporation headquartered in Tarrytown, New York.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on a corporate event rather than periodic financial performance data.
Material Changes
- Acquisition Completion: On April 30, 2014, the Company completed the previously announced acquisition of Hydralyte from Hydralyte Pharmaceuticals Trust of Victoria, Australia.
- Strategic Position: Hydralyte is identified as the leading over-the-counter oral rehydration brand in Australia.
- Operational Integration: The acquired brand will be marketed and sold through Care Pharmaceuticals, the Company's Australian subsidiary.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future outlook, specific risk factors, or contingencies related to the transaction. The document serves strictly to announce the completion of the acquisition.
Investor Verification Checklist
- Verify the purchase price and consideration structure for the Hydralyte acquisition in the referenced Press Release (Exhibit 99.1) or prior filings.
- Confirm the impact of the acquisition on the Company's consolidated financial statements in the next quarterly report (10-Q).
- Review the regulatory approval status for the integration of Hydralyte into Care Pharmaceuticals.